Explore All 460 Buyout (LBO, MBO, MBI) Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | June 17, 2024 |
| Target | ABS |
| Sector | Life Science |
| Buyer(s) | 3 Boomerang Capital |
| Deal Type | Buyout (LBO, MBO, MBI) |
FILTER BY
3?Boomerang?Capital is a private equity firm focused on lower-middle-market healthcare companies. The Firm looks to partner with healthcare entrepreneurs and provide flexible, patient capital combined with strategic guidance and operational expertise. Specific areas of focus includes biopharma outsourcing, medical device & diagnostic manufacturing, healthcare IT/tech-enabled services, and alternate site care. 3 Boomerang Capital was formed in 2023 and is based in Greenwich, Connecticut.
| Deal Context for Buyer | # |
|---|---|
| Overall | 1 of 2 |
| Sector: Life Science | 1 of 1 |
| Type: Buyout (LBO, MBO, MBI) | 1 of 2 |
| State: Delaware | 1 of 1 |
| Country: United States | 1 of 2 |
| Year: 2024 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-06-03 |
LSOMS Holdings
Greenwich, Connecticut, United States LSOMS Holdings provides quality, regulatory, and operational excellence consulting to biopharmaceutical, medical device, and CDMO companies worldwide. LSOMS Holdings is based in Greenwich, Connecticut. |
Buy | - |
